Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis - Concepedia

Concepedia

Publication | Closed Access

Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis

48

Citations

26

References

2018

Year

Marita Zimmermann, Elizabeth Brouwer, Jeffrey A. Tice, Matt Seidner, Anne Loos, Shanshan Liu, Richard H. Chapman, Varun Kumar, Josh J. Carlson

Cost-utility AnalysisDisease ProgressionDisease-modifying TherapiesNeurological DisorderClinical TrialsNeurologyCost EffectivenessMultiple SclerosisNeurorehabilitationMedicine

References

	Year	Citations

Page 1

Page 1